코오롱티슈진

1 known investors

Kolon TissueGene is a clinical-stage biopharmaceutical company developing cell therapies for degenerative musculoskeletal diseases. Its lead investigational drug, TG-C, is in Phase III trials as a treatment for knee osteoarthritis aimed at reducing pain, improving function, and slowing disease progression.

BiotechHealthtechMedical Devices